Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-17 | Mr. Girin received an engineering education at the French Ecole des Mines. With over two decades of experience as an executive and director in the medical device industry, both in the U.S. and in Europe, we believe Mr. Girin brings invaluable industry experience and leadership qualities to the Board. |
| 2016-04-25 | Mr. Girin received an engineering education at the French Ecole des Mines. |
| 2016-06-06 | Pascal E.R. Girin Includes 35,000 shares that Mr. Girin has the right to acquire through the exercise of options. |
| 2017-09-05 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. Since September 2016, Mr. Girin has served as Chairman and CEO of Balt Inc., a private company specialized in the treatment of neurovascular diseases. |
| 2018-04-30 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. Mr. Girin received an engineering education at the French Ecole des Mines. |
| 2019-04-16 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. Since September 2016, Mr. Girin has served as Chairman and CEO of Balt Inc., a private company specialized in the treatment of neurovascular diseases. |
| 2020-04-20 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. Since December 2018, Mr. Girin has served as President and CEO of Balt SAS, a private company specialized in the treatment of neurovascular diseases... Mr. Girin received an engineering education at the French Ecole des Mines. |
| 2021-04-19 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. |
| 2022-04-11 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. |
| 2023-04-14 | Mr. Girin received an engineering education at the French Ecole des Mines. |
| 2024-04-05 | Mr. Girin possesses over two decades of management and executive experience in the field of medical technology. Since September 2016, Mr. Girin has served as President and CEO of Balt SAS, a private company specializing in the treatment of neurovascular diseases. |
Data sourced from SEC filings. Last updated: 2026-02-08